Glycolipid Disialoganglioside-directed Antibody [EPC] - N0000191500

Pharmacologic Class Information

Pharmacologic Code N0000191500
Pharmacologic Name Glycolipid Disialoganglioside-directed Antibody
Pharmacologic Uses
  • GD2-binding monoclonal antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Glycolipid Disialoganglioside-directed Antibody

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Glycolipid Disialoganglioside-directed Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
66302-014Unituxin Non-Proprietary Name: DinutuximabInjectionIntravenousUnited Therapeutics CorporationACTIVE
73042-201Danyelza Non-Proprietary Name: NaxitamabInjectionIntravenousY-mabs Therapeutics, Inc.ACTIVE